Contineum Therapeutics, Inc. (NASDAQ:CTNM) IPO
IPO
Priced at US$16.00 a share on Apr 4, 2024.
- Price
- US$16.00 a share
- Shares offered
- 6,875,000 shares of Class A common stock
- Offering size
- US$110 million
- Underwriters' option
- Up to 1,031,250 more shares
- Underwriters
- Goldman Sachs & Co. LLC, Morgan Stanley, Stifel, RBC Capital Markets · In the order on the cover
- Shares delivered
- On or about Apr 9, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 13, 2023 |
| Filed publicly | Mar 15, 2024 |
| Amended once | Apr 1, 2024 |
| Shares registered with an exchange | Apr 2, 2024 |
| Declared effective by the SEC | Apr 4, 2024 |
| Final prospectus, with the price | Apr 8, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 8, 2024 |
| EFFECT · Notice that a registration is effective | Apr 4, 2024 |
| CERT · Exchange's certificate of listing | Apr 4, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 2, 2024 |
| CORRESP · Letter to the SEC | Apr 2, 2024 |
| CORRESP · Letter to the SEC | Apr 2, 2024 |
| S-1/A · Registration statement, amended | Apr 1, 2024 |
| CORRESP · Letter to the SEC | Mar 21, 2024 |
| CORRESP · Letter to the SEC | Mar 15, 2024 |
| S-1 · Registration statement | Mar 15, 2024 |
| UPLOAD · Letter from the SEC | Feb 23, 2024 |
| DRSLTR · Letter to the SEC with a draft | Feb 15, 2024 |
| DRS/A · Draft registration statement, amended | Feb 15, 2024 |
| UPLOAD · Letter from the SEC | Feb 7, 2024 |
| DRSLTR · Letter to the SEC with a draft | Jan 29, 2024 |
| DRS/A · Draft registration statement, amended | Jan 29, 2024 |
| UPLOAD · Letter from the SEC | Jan 11, 2024 |
| DRS · Draft registration statement | Dec 13, 2023 |
From the cover of the final prospectus (424B4) filed Apr 8, 2024